Blake Borgeson plans sale of 220,000 RXRX shares

This Form 144 notice shows Blake C. Borgeson planning to sell up to 220,000 shares of the issuer’s Class A stock through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of $924,000.

Accepted by SEC EDGAR 02/03/2026 - 11:26 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

This Form 144 notice shows Blake C. Borgeson planning to sell up to 220,000 shares of the issuer’s Class A stock through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of $924,000.

The filing also describes how these securities were acquired as founder shares from the issuer in two compensation grants of 110,000 Class A shares each on 09/01/2016 and 09/01/2017.

Over the past three months, Borgeson has already sold 220,000 Class A shares on 12/02/2025 for gross proceeds of $961,400 and another 220,000 shares on 01/06/2026 for $959,200.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for RXRX disclose about planned share sales?

The Form 144 discloses that Blake C. Borgeson plans to sell up to 220,000 Class A shares through Fidelity Brokerage Services on NASDAQ, with an indicated aggregate market value of about $924,000 for this planned transaction.

How many RXRX shares did Blake C. Borgeson sell in the last three months?

The filing shows Borgeson sold 220,000 Class A shares on 12/02/2025 for $961,400 and another 220,000 shares on 01/06/2026 for $959,200, totaling 440,000 shares sold in the last three months.

How were the RXRX shares in this Form 144 originally acquired?

The shares were acquired as founder shares directly from the issuer. The filing lists two compensation grants of 110,000 Class A shares each, dated 09/01/2016 and 09/01/2017, both identified as compensation rather than cash purchases.

What is the relationship between the planned RXRX sale and total shares outstanding?

The notice shows 220,000 Class A shares are planned for sale, while 514,895,802 shares of that class are outstanding. This provides context on the scale of the planned sale relative to the issuer’s overall Class A share base.

Which broker and exchange are involved in the planned RXRX share sale?

The planned sale of 220,000 Class A shares is listed as being placed through Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island, with the securities identified for trading on the NASDAQ exchange.

On what approximate date are the RXRX shares in this Form 144 expected to be sold?

The document lists an approximate sale date of 02/03/2026 for the planned sale of 220,000 Class A shares. This date reflects when the filer expects to execute the transaction, subject to market conditions and applicable Rule 144 requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001856094
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RECURSION PHARMACEUTICALS, INC.
SEC File Number	001-40323
Address of Issuer	41S RIO GRANDE STREET SALT LAKE CITY UTAH 84101
Phone	(385) 269-0203
Name of Person for Whose Account the Securities are To Be Sold	Borgeson Blake
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	220000	924000.00	514895802	02/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/01/2016	Founders Shares	Issuer			110000	09/01/2016	Compensation
Class A	09/01/2017	Founders Shares	Issuer			110000	09/01/2017	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Blake C. Borgeson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	12/02/2025	220000	961400.00
Blake C. Borgeson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	01/06/2026	220000	959200.00

144: Remarks and Signature

Remarks
Date of Notice	02/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/31/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Blake C. Borgeson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)